196 related articles for article (PubMed ID: 12680750)
1. Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care.
Denys D; van Megen HJ; Westenberg HG
J Psychopharmacol; 2003 Mar; 17(1):127-9. PubMed ID: 12680750
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine-Induced Skin Picking and Compulsive Behaviors in a Preschool Girl.
Çoşkun F; Bilgiç A
Clin Neuropharmacol; 2018; 41(5):192-193. PubMed ID: 30024442
[TBL] [Abstract][Full Text] [Related]
3. Obsessive-compulsive spectrum disorders: effective treatment with paroxetine.
Ravindran AV; Lapierre YD; Anisman H
Can J Psychiatry; 1999 Oct; 44(8):805-7. PubMed ID: 10566112
[TBL] [Abstract][Full Text] [Related]
4. Serotonin syndrome and fluvoxamine: a case study.
Bastani JB; Troester MM; Bastani AJ
Nebr Med J; 1996 Apr; 81(4):107-9. PubMed ID: 8628448
[TBL] [Abstract][Full Text] [Related]
5. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
Bailly D
Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514
[TBL] [Abstract][Full Text] [Related]
6. Near-fatal skin picking from delusional body dysmorphic disorder responsive to fluvoxamine.
O'Sullivan RL; Phillips KA; Keuthen NJ; Wilhelm S
Psychosomatics; 1999; 40(1):79-81. PubMed ID: 9989126
[No Abstract] [Full Text] [Related]
7. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.
Mundo E; Bianchi L; Bellodi L
J Clin Psychopharmacol; 1997 Aug; 17(4):267-71. PubMed ID: 9241005
[TBL] [Abstract][Full Text] [Related]
8. Fluvoxamine: new indication. No progress in obsessive-compulsive disorder.
Prescrire Int; 2004 Oct; 13(73):163-5. PubMed ID: 15499694
[TBL] [Abstract][Full Text] [Related]
9. Disinhibition as a side effect of treatment with fluvoxamine in pediatric patients with obsessive-compulsive disorder.
Harris E; Eng HY; Kowatch R; Delgado SV; Saldaña SN
J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):347-53. PubMed ID: 20807074
[TBL] [Abstract][Full Text] [Related]
10. Open-label escitalopram treatment for pathological skin picking.
Keuthen NJ; Jameson M; Loh R; Deckersbach T; Wilhelm S; Dougherty DD
Int Clin Psychopharmacol; 2007 Sep; 22(5):268-74. PubMed ID: 17690595
[TBL] [Abstract][Full Text] [Related]
11. SSRI-induced mania in obsessive-compulsive disorder.
Diler RS; Avci A
J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):6-7. PubMed ID: 9893408
[No Abstract] [Full Text] [Related]
12. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
Matsunaga H; Nagata T; Hayashida K; Ohya K; Kiriike N; Stein DJ
J Clin Psychiatry; 2009 Jun; 70(6):863-8. PubMed ID: 19422759
[TBL] [Abstract][Full Text] [Related]
13. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Pigott TA; Seay SM
J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
[TBL] [Abstract][Full Text] [Related]
14. [Selective serotonin reuptake inhibitor(SSRI)].
Motohashi N
Nihon Rinsho; 2001 Aug; 59(8):1519-22. PubMed ID: 11519151
[TBL] [Abstract][Full Text] [Related]
15. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Maina G; Albert U; Salvi V; Bogetto F
J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
[TBL] [Abstract][Full Text] [Related]
16. When to Choose Paroxetine Treatment in Skin-Picking Disorder: A Case Report.
Arıkan MK; Oba MÇ; İlhan R; Mat MC
Clin EEG Neurosci; 2023 Mar; 54(2):168-172. PubMed ID: 34994223
[TBL] [Abstract][Full Text] [Related]
17. Fluvoxamine-Associated Galactorrhea: A Case Report.
Chakladar A; Singh J; Tak NK; Patra BN; Sagar R
J Clin Psychopharmacol; 2020; 40(1):101-102. PubMed ID: 31804454
[No Abstract] [Full Text] [Related]
18. Photosensitivity reaction associated with selective serotonin re-uptake inhibitors: possible cross-sensitivity?
Cheng YC; Huang MC
Psychiatry Clin Neurosci; 2014 Mar; 68(3):244. PubMed ID: 24895743
[No Abstract] [Full Text] [Related]
19. Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial.
Shalbafan M; Malekpour F; Tadayon Najafabadi B; Ghamari K; Dastgheib SA; Mowla A; Shirazi E; Eftekhar Ardebili M; Ghazizadeh-Hashemi M; Akhondzadeh S
J Psychopharmacol; 2019 Nov; 33(11):1407-1414. PubMed ID: 31575326
[TBL] [Abstract][Full Text] [Related]
20. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.
Figgitt DP; McClellan KJ
Drugs; 2000 Oct; 60(4):925-54. PubMed ID: 11085201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
